INSM
Insmed Incorporated · Healthcare · Biotechnology
Señales de momentum (gestores comparables): amplitud de titulares 0.0% · flujo de acciones +6.4% · nuevas posiciones netas 0.0% — fórmula
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q4 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 158 | -6 | 147.56M | $15.74B | +6 | −11 |
| Q1 2026 | 166 | +6 | 152.11M | $24.63B | +9 | −4 |
| Q4 2025 | 159 | -1 | 156.45M | $27.23B | +1 | −1 |
| Q3 2025 | 21 | +1 | 121.03M | $17.43B | +1 | −1 |
| Q2 2025 | 18 | +1 | 70.35M | $7.08B | +2 | −1 |
| Q1 2025 | 14 | -1 | 33.99M | $2.59B | — | −1 |
| Q4 2024 | 15 | 0 | 31.46M | $2.17B | +1 | −1 |
| Q3 2024 | 14 | -1 | 23.46M | $1.71B | — | −1 |
| Q2 2024 | 15 | — | 25.91M | $1.74B | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 12.70M | +1.0% | $877.11M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 12.70M | +1.0% | $877.11M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 3 | State Street Global Advisors ✦ (pasivo) | 6.11M | — | $421.57M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | State Street Global Advisors ✦ (pasivo) | 6.11M | — | $421.57M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Geode Capital Management ✦ (pasivo) | 4.09M | +7.2% | $282.24M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Geode Capital Management ✦ (pasivo) | 4.09M | +7.2% | $282.24M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 7 | Norges Bank ✦ (pasivo) | 1.83M | +10.7% | $126.61M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 8 | Adage Capital Partners ✦ | 1.65M | +59.6% | $113.75M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 9 | Marshall Wace ✦ | 1.06M | +38.0% | $73.47M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 10 | Wellington Management ✦ | 752.23K | -21.8% | $51.93M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 11 | Wellington Management ✦ | 752.23K | -21.8% | $51.93M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 12 | Wellington Management ✦ | 752.23K | -21.8% | $51.93M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 13 | Wellington Management ✦ | 752.23K | -21.8% | $51.93M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 14 | Wellington Management ✦ | 752.23K | -21.8% | $51.93M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 15 | Wellington Management ✦ | 752.23K | -21.8% | $51.93M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 16 | Millennium Management ✦ | 699.01K | +23.8% | $48.26M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 17 | Millennium Management ✦ | 699.01K | +23.8% | $48.26M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 18 | Two Sigma Investments ✦ | 594.00K | -25.9% | $41.01M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 19 | Duquesne Family Office ✦ | 593.47K | +2867.3% | $40.97M | 1.2% | ▲ Add | 3 | SEC ↗ |
| 20 | D. E. Shaw & Co. ✦ | 508.79K | +662.4% | $35.13M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 21 | D. E. Shaw & Co. ✦ | 508.79K | +662.4% | $35.13M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 22 | Soros Fund Management ✦ | 455.09K | -4.9% | $31.42M | 0.8% | ▼ Trim | 3 | SEC ↗ |
| 23 | Citadel Advisors ✦ | 323.74K | -3.8% | $22.35M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 24 | Citadel Advisors ✦ | 323.74K | -3.8% | $22.35M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 25 | AQR Capital Management ✦ | 64.17K | +2.0% | $4.43M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 26 | AQR Capital Management ✦ | 64.17K | +2.0% | $4.43M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 27 | AQR Capital Management ✦ | 64.17K | +2.0% | $4.43M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 28 | Renaissance Technologies ✦ | 25.29K | Nuevo | $1.75M | 0.0% | New | 1 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Renaissance Technologies | $1.75M | 0.0% |
Posición cerrada
| Point72 Asset Management | $23.01M | era 0.1% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 664 tenedores, 192.22M acciones, $30.07B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Director · 5.00K acc. · $637,650
Officer · 239.85K acc. · $31.96M
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología